Tag: renal denervation

SCAI releases proceedings from expert consensus roundtable on renal denervation treatment...

The Society for Cardiovascular Angiography and Interventions (SCAI) has released a proceedings document outlining the possible role of renal denervation (RDN) as a therapeutic...
denervation

Multi-organ denervation to combat cardiometabolic disease: A novel concept put to...

Following a successful proof-of-concept study, Gerard S Goh and Markus P Schlaich have embarked upon a first-in-human study to explore the safety and efficacy...
ultrasound renal denervation

ACC.21: Ultrasound renal denervation shown to reduce blood pressure in resistant...

Ultrasound-based endovascular renal denervation can successfully reduce systolic blood pressure in patients with medication-resistant hypertension, as demonstrated by the results of a late-breaking clinical...

EuroPCR 2021: Late-breaking data demonstrate long-term benefits of Medtronic radiofrequency renal...

Medtronic today announced new clinical data from the Global SYMPLICITY registry (GSR) indicating that renal denervation with the Medtronic Symplicity renal denervation system was...
metavention modus study

Metavention announces initiation of “groundbreaking” multi-organ denervation study

Metavention, a Minneapolis-headquartered medical device company, has announced the initiation of the MODUS study to treat patients with both type 2 diabetes and hypertension...
brattea renal denervation

Renal denervation firm Brattea completes US$20 million Series B+ funding round

Shanghai-based renal denervation (RDN) company Brattea has announced the successful completion of a Series B+ funding round worth more than US$20 million led by...